While the mechanisms of migraine are still poorly understood, insights from clinical and preclinical studies over the past three decades have focused attention on two neuropeptides: calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP). The gene discussed is ADCYAP1; the disease is migraine disorder.